Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 26, 1997

View Archived Issues

Mochida product pipeline in review

Meiji Seika's pipeline

Company Profile: Pharmadigm

Company Profile: AMBI

Immunoregulatory protein discovered by Boehringer Mannheim

5-HT2C antagonists from Roche

MS&D discloses tachykinin antagonists

Adenosine antagonists claimed by Fujisawa

Lilly claims compounds for postmenopausal syndrome

Melatonin agonists from Takeda

New contrast agents from Guerbet

Thrombin inhibitors from Merck & Co.

PLA2 inhibitors revealed by Mitsui Toatsu

Hisamitsu reports antiallergic agents

New approach to brain cancer introduced

Approval recommended for ultrasound contrast agent

Zanamivir enters pivotal trials

Third pivotal trial for lisofylline

Preliminary clinical data reported for OP-1

Bayer and Zeneca to comarket Ca antagonist

Recurrent herpes treatment development advances

Bio-Technology General grants license to BioLon in Japan

Pfizer licenses potential stroke therapy

Sano begins pivotal trials with smoking cessation product

Favorable results reported for Mentax

Cytel and Sumitomo expand agreement

Flamel Technologies and SKB conclude collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...